NASDAQ:STAA
Staar Surgical Co.
Staar Surgical Co.'s revenue fell 23.7% in fiscal 2025 to $239.4M while operating margin fell to −38.3%, its lowest in 10 years. Free cash flow was −$40.0M, −16.7% of revenue, and the diluted share count rose 0.9%.Summary generated from Staar Surgical Co.'s SEC filings. Latest annual report filed Mar 3, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$239.4M
Revenue growth−23.7%
Revenue, 5-yr CAGR+7.9%
Gross margin76.2%
Operating margin−38.3%
Net margin−33.6%
ROICn/a
Return on equity−21.7%
Debt / equityn/a
Free cash flow−$40.0M
FCF margin−16.7%
Share count change+0.9%
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 230 | 239 | 322 | 314 | 239 |
| Operating income | 33 | 44 | 28 | −13 | −92 |
| Net income | 28 | 40 | 21 | −20 | −80 |
| Free cash flow | 30 | 18 | −4 | −8 | −40 |
Recent filings
- 8-K/AAmended director or officer change
Oct 5, 2026 - 8-KDirector or officer change
Sep 10, 2026 - 4Insider transaction report
Aug 18, 2026 - 4Insider transaction report
Aug 18, 2026 - 10-QQuarterly report for the period ended Jul 3, 2026
Aug 12, 2026 - 8-KResults of operations and financial condition
Aug 12, 2026 - 8-KDirector or officer change
Aug 6, 2026 - 8-KDirector or officer change
Jun 22, 2026